by RIVANNA | Apr 29, 2026 | Press Releases
CHARLOTTESVILLE, VA, APRIL 29, 2026 — RIVANNA®, developer of AI-powered clinical decision-support solutions, recently published the findings of a study demonstrating that the novel, automated musculoskeletal imaging system Accuro® XV can produce diagnostic images of...
by RIVANNA | Apr 21, 2026 | Press Releases
Company accelerates AI-enabled fracture detection development, compressing anticipated FDA 510(k) timeline CHARLOTTESVILLE, VA, APRIL 22, 2026 — RIVANNA®, developer of AI-enabled clinical decision-support solutions, announced that it has expanded its clinical studies...
by RIVANNA | Apr 21, 2026 | News
Neuraxial anesthesia remains a foundational component of modern anesthetic practice, supporting procedures ranging from labor analgesia to major surgical interventions. In 2026, the field continues to evolve under the combined influence of clinical complexity,...
by RIVANNA | Apr 15, 2026 | News
This content was reviewed by Stephen Garber, MD, Anesthesiologist in Southern California, and updated in 2026 to reflect current clinical evidence, quality frameworks, and recent guidance. Anesthesiology is changing under real operational pressure. The case mix is...
by RIVANNA | Mar 11, 2026 | News
For RIVANNA, AI can help clinicians metaphorically see through walls by layering information on top of ultrasound to achieve X-ray-like performance without radiation. Co-founded in 2010 by CEO Will Mauldin, PhD, the company emerged when the first handheld ultrasound...
